Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Black

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Computers, Informatics, Nursing : CIN|November 11, 2016
Accuracy and Efficiency of Recording Pediatric Early Warning Scores Using an Electronic Physiological Surveillance System Compared With Traditional Paper-Based DocumentationGerri Sefton, Steven Lane, Roger Killen, et al.
Journal of Gastroenterology|November 23, 2016
The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III studyHiromitsu Kumada, Yoshiyuki Suzuki, Yoshiyasu Karino, et al.
Molecular Cancer Therapeutics|February 3, 2016
Dissecting Therapeutic Resistance to ERK InhibitionSharda Jha, Erick J Morris, Alan Hruza, et al.
Gastroenterology|October 11, 2016
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C InfectionPaul Kwo, Edward J Gane, Cheng-Yuan Peng, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2018
Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncologySobhana Babu Boga, Abdul-Basit Alhassan, Alan B Cooper, et al.
Chemmedchem|March 12, 2015
P2-quinazolinones and bis-macrocycles as new templates for next-generation hepatitis C virus NS3/4a protease inhibitors: discovery of MK-2748 and MK-6325Michael T Rudd, John W Butcher, Kevin T Nguyen, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for OncologySobhana Babu Boga, Yongqi Deng, Liang Zhu, et al.
Cancer Discovery|April 26, 2013
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsErick J Morris, Sharda Jha, Clifford R Restaino, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Computers, Informatics, Nursing : CIN|November 11, 2016
Accuracy and Efficiency of Recording Pediatric Early Warning Scores Using an Electronic Physiological Surveillance System Compared With Traditional Paper-Based DocumentationGerri Sefton, Steven Lane, Roger Killen, et al.
Journal of Gastroenterology|November 23, 2016
The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III studyHiromitsu Kumada, Yoshiyuki Suzuki, Yoshiyasu Karino, et al.
Molecular Cancer Therapeutics|February 3, 2016
Dissecting Therapeutic Resistance to ERK InhibitionSharda Jha, Erick J Morris, Alan Hruza, et al.
Gastroenterology|October 11, 2016
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C InfectionPaul Kwo, Edward J Gane, Cheng-Yuan Peng, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2018
Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncologySobhana Babu Boga, Abdul-Basit Alhassan, Alan B Cooper, et al.
Chemmedchem|March 12, 2015
P2-quinazolinones and bis-macrocycles as new templates for next-generation hepatitis C virus NS3/4a protease inhibitors: discovery of MK-2748 and MK-6325Michael T Rudd, John W Butcher, Kevin T Nguyen, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for OncologySobhana Babu Boga, Yongqi Deng, Liang Zhu, et al.
Cancer Discovery|April 26, 2013
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsErick J Morris, Sharda Jha, Clifford R Restaino, et al.
Pageof 5